Product Information
IBUPROFEN 200 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0320 per EA under NDC 00904791461. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
200 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904791461
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA075139On Market Since
3/1/1999
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 200 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 17.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0320 per EA |
|---|---|
| All-time high | $0.0370 (Nov 12, 2025) |
| All-time low | $0.0250 (Jul 19, 2017) |
| 52-week high | $0.0370 |
| 52-week low | $0.0320 |
| Median price | $0.0320 |
| Average price | $0.0312 |
| Largest weekly change | -15.1% (Jul 19, 2017) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IBUPROFEN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 200 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0320 per EA (NDC 00904791461), effective Jun 24, 2026.
How has the price of IBUPROFEN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 200 MG TABLET has risen 17.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 200 MG TABLET?
Since Nov 28, 2013, the NADAC for IBUPROFEN 200 MG TABLET has ranged from a low of $0.0250 (Jul 19, 2017) to a high of $0.0370 (Nov 12, 2025), with a median of $0.0320 per EA.
Are there cheaper alternatives to IBUPROFEN 200 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as IBUPROFEN 200 MG TABLET, but none are currently priced below it.
Who manufactures IBUPROFEN 200 MG TABLET?
IBUPROFEN 200 MG TABLET (NDC 00904791461) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification